Assuming this model, we could interpret the elimination of the Vav1-Cbl-b-ICN1 axis in this latter phase as a way to ensure higher levels of ICN1 signaling in fully developed T-ALL cells irrespective of the mutational status of the Notch1 pathway. The gene discussed is VAV1; the disease is acute lymphoblastic leukemia.